SCHEMBL17028752

SCHEMBL17028752

CC(=O)c1ccccc1F.CC(C)(C)[S+]([O-])N=CCc1ccccc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.38
RAB9A P51151 4/20 0.38
NOD2 Q9HC29 1/20 0.38
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 4/20 0.36
LMNA P02545 3/20 0.36
HTT P42858 1/20 0.36
RIPK1 Q13546 2/20 0.35
MAOB P27338 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
PTPN1 P18031 1/20 0.34
ERCC5 P28715 1/20 0.34
FEN1 P39748 1/20 0.34
KMT2A Q03164 2/20 0.33
GAA P10253 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ATM Q13315 1/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17028760 0.87 GPR3 (0.38) ALDH1A1LMNARIPK1MAOB
SCHEMBL17028761 0.87 GPR3 (0.38) ALDH1A1LMNARIPK1MAOB
SCHEMBL620590 0.87 GPR3 (0.38) ALDH1A1LMNARIPK1MAOB
SCHEMBL15867596 0.82 PPARG (0.31)
SCHEMBL15994995 0.80 RIPK1 (0.35) RIPK1
SCHEMBL17749309 0.80 RIPK1 (0.35) RIPK1
SCHEMBL15994994 0.80 RIPK1 (0.35) RIPK1
SCHEMBL30681392 0.76 GPR3 (0.30)
SCHEMBL2582230 0.75 TAAR1 (0.40) RIPK1MAOBKMT2AMEN1
SCHEMBL15994452 0.73 P2RX7 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3107897-A1 2-AMINO-3, 5, 5-TRIFLUORO-3, 4, 5, 6-TETRAHYDROPYRIDINES AS BACE1 INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE H. Lundbeck A/S (DK) 2016-12-28 EP disclosed
WO-2015124576-A1 2-AMINO-3, 5, 5-TRIFLUORO-3, 4, 5, 6-TETRAHYDROPYRIDINES AS BACE1 INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE H. LUNDBECK A/S (DK) 2015-08-27 WO disclosed